Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access Recommendations for a Public Health Approach 2010 Revision. WHO (2010)

Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access Recommendations for a Public Health Approach 2010 Revision. WHO (2010) Tremendous progress has been made over the past few years in diagnosing and treating infants and children with human immunodeficiency virus (HIV) infection. However, much remains to be done to effectively scale-up and sustain prevention efforts and treatment services for all in need. The most efficient and cost-effective way to tackle paediatric HIV globally is to reduce mother-to-child transmission (MTCT). In 2008, an estimated 45% of pregnant women living with HIV received antiretrovirals (ARVs) to prevent transmission of HIV to their children. However, every day, there are nearly 1 200 new infections in children less than 15 years of age, more than 90% of them occurring in the developing world and most being the result of transmission from mother to child.

Download this publication

Good Practice Guide: Improving Access to Treatment with Flexibilities in the WTO TRIPS Agreement. UNDP. (2010)

immage

Analyses public health flexibilities in the TRIPS Agreement and provides examples where and how have they been used by governments. It can be used by legislators and policy makers in discussions on adopting or reforming legislation, in formulating national intellectual property rights (IPR) and public health policies, and in negotiating WTO accession agreements, or bilateral trade agreements.


Keywords: HIV treatment, ARV, civil society, data

Download Publication

Policies and Guidelines on the Prevention of Mother to Child Transmission (PMTCT) of Human Immunodeficiency Virus (HIV). Department of Health, Philippines. (2009)

immage

These guidelines are intended to provide guidance on PMTCT of HIV among Sexually Transmitted Infection (STI), Maternal and Child Health (MCH), Family Planning (FP), sexual and reproductive health (SRH) service providers covering public and privare, community-based health facilities and the civil society.

 

 

 

 

Download Document

Regional Workshop on Strengthening ART Data Use in Asia and the Pacific. USAID and WHO (2009)

Regional Workshop on Strengthening ART Data Use in Asia and the Pacific. USAID and WHO (2009) Antiretroviral treatment (ART) is extending the lives of people living with HIV (PLHIV). Though ART has become more widely accessible globally since the early 1990s, getting antiretroviral drugs (ARV) to those who need it most continues to be a challenge. As access increases, so does the need to assure that systems are in place to report on outputs and outcomes in a timely manner. Such data are vital to ART programs, as not only do they assist in tracking progress towards achieving global goals, but they also inform the day- to-day implementation of treatment programs.

Download this publication

Access to HIV-related Health Services in Positive Women, Men Who Have Sex with Men (MSM), Transgender (TG) and Injecting Drug Users (IDU) - Research Finding Highlights. APN+. (2009)

APN access_to_treatment_among_MSM

In July 2008, the Asia Pacific Network of People Living with HIV/AIDS (APN+) conducted a network-based research project aimed to explore the experience of women, MSM/TG, and IDUs living with HIV in accessing ART and other HIV-related healthcare services. Specifically, the study examined the experience of PLHIV with linkages to PLHIV support organizations and services in areas of HIV counselling and testing, ART adherence, treatment for opportunistic infections (OIs) and healthcare providers’ (HCPs) attitude toward the targeted marginalized groups.

 

 

Download this publication

Factsheet N°4: Anti‐Retroviral Therapy (ART) Services in Nepal. National Centre for AIDS and STD Control Teku, Kathmandu (2009)

Factsheet N°4: Anti‐Retroviral Therapy (ART) Services in Nepal. National Centre for AIDS and STD Control Teku, Kathmandu (2009) Facts and Figures on ART in Nepal: - Anti‐retroviral treatment started in Nepal in February 2004 from Teku Hospital. - Government is providing free of cost ART service for all those in need. - There is a National ART Guidelines and SOP for the clinical management of ART in Nepal.

Download this publication

Five-Year Experience with Scaling-Up Access to Antiretroviral Treatment in an HIV Care Programme. Thai S, Koole O, Ros PU, et al (2009)

Five-Year Experience with Scaling-Up Access to Antiretroviral Treatment in an HIV Care Programme. Thai S, Koole O, Ros PU, et al (2009) To evaluate a 5-year HIV care programme (2003–2007) in the Sihanouk Hospital Center of HOPE, Phnom Penh, Cambodia. Analysis of routine programme indicators per year: number of new patients, active patients, antiretroviral therapy (ART) coverage in the cohort, mortality and loss to follow-up. Comparison of mortality before and after the start of ART using Kaplan–Meier survival curves. Analysis of risk factors using Cox regression for the combined endpoint of mortality and loss to follow-up in patients on ART.

Download this publication

HIV Testing, Treatment and Prevention: Generic Tools for Operational Research. Obermeyer C Makhlouf, Bott S, Carrieri P, et al (2009)

Generic tools_for_operational_research_22.2_and_5.3

The combined efforts of countries and international partners have resulted in substantial advances in HIV treatment and prevention. Nonetheless, access to key HIV services remains low in many settings around the world, and there are still major research gaps about the best way to expand HIV testing, prevention and treatment, especially in resource-limited settings. The World Health Organization (WHO) has endorsed the “learning by doing” approach, which advocates that public health strategies to scale up HIV treatment and prevention services be continuously reviewed, evaluated and revised, so that the results of research can inform programmes as quickly as possible (WHO 2006).


Download this publication

Recurrent Costs of India’s Free ART Program. Gupta I, Trivedi M and Kandamuthan S (2009)

Recurrent Costs of India’s Free ART Program. Gupta I, Trivedi M and Kandamuthan S (2009) In April 2004, the government of India announced the Free Antiretroviral Treatment (ART) Program, which brought first-line antiretroviral (ARV) drugs within the reach of a much larger pool of ARV-eligible individuals. However, the full costs of providing treatment, the share of costs across enti- ties involved directly or indirectly in the program, and the possible financial implications of a more scaled-up program were not much discussed or ana- lyzed in the country, leaving open many questions regarding the cost of the program and the implications of scaling up access to treatment.

Download this publication

Missing the Target 7: Failing Women, Failing Children: HIV, Vertical Transmission and Women’s Health. International Treatment Preparedness Coalition (2009)

Missing the Target 7: Failing Women, Failing Children: HIV, Vertical Transmission and Women’s Health. International Treatment Preparedness Coalition (2009) Research conducted for Missing the Target 7 by civil society activists on-the-ground in six countries (Argentina, Cambodia, Moldova, Morocco, Uganda, and Zimbabwe) shows that efforts to prevent vertical transmission are failing to reach the very group it was designed for - HIV-positive pregnant women.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_Progress_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_National_and_Subnational_HIV_Estimates_and_Projections_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_NASA_Report_2016-2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_TB_Global_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-Global-AIDS-Update_Asia-Pacific_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-changing-laws-that-discriminate_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_HIV_National_Strategic_Information_2018-22.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/PNG_National_STI_and_HIV_Strategy.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
Calendar of events
Mar
1
(1 Mar - 1 Mar)
Mar
3
Mar
8
(8 Mar - 8 Mar)